Authors
Latest:
GS1 standards are vital for pharma serialization‘Future proof’ your implementation by adhering to industry standards
Latest:
Online personal data will be a boon for patient supportSpecialty-pharma support providers have a potential benefit in behavioral targeting insights
Latest:
First physicians, now patients: Risk avoidance in patient support programsA look into the growing compliance risks associated with patient services
Latest:
Pragmatic randomized clinical trials: Real-world evidence made for payers and regulatorsA complement to the classic randomized clinical trial may benefit drug commercialization
Latest:
The Battle for Control of Specialty DrugsSpecialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement
Latest:
Analyzing drug-pricing mechanismsPricing systems in US drug supply chain have many limitations; an analytics-based method might avoid some of them
Latest:
Generic Manufacturers Gain Another Advantage in Disputing Drug PatentsFDA sets a precedent for granting generic approvals even when initial litigation goes against the generic manufacturer
Latest:
Make your CRM vendor a true partner to your sales teamToday's cloud-based, fast-evolving CRM systems call for a closer partnership between vendor and client
Latest:
Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patentingMultiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another
Latest:
Manufacturers can support the ICD-10 transitionHealthcare's conversion to a new coding system can affect drug prescribing. Here's what you need to know
Latest:
Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of CapitalInvestment funds have developed an interest in trading capital for royalties on drug commercializations
Latest:
Active packaging protects oral solid formulationsNew technologies offer improved shelf life for moisture- and oxygen-sensitive oral solids
Latest:
The Truth Behind IDNs: Is It Who You Know, or What You Know?Connecting with buying influences in integrated delivery networks is a challenge
Latest:
The Drive to Develop New Commercial ModelsIndustry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process
Latest:
REMS Drives Manufacturer-Specialty Pharmacy RelationshipsSpecialty pharmacies are competing to position themselves as the best partners for manufacturers dealing with high-touch, high-risk products
Latest:
Pharma in China--calculated risk gone wrongDoing business in China is undergoing important changes
Latest:
AstraZeneca's Principles for Product-Related Online CommunicationsIndustry anticipates meaningful guidance from FDA on use of social media
Latest:
Cloud-based services manage regulated content betterUnifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy
Latest:
Pharma's stake in comparative effectiveness researchWhen drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful
Latest:
Follow the Money... Where Healthcare Policy is HeadedCMS will be changing reimbursement practices regardless of how healthcare reform plays out
Latest:
Pharma pricing and antitrust lawUS courts fail to clarify when pricing may violate antitrust laws
Latest:
The Evolving Retail Pharmacy Channel: Implications for ManufacturersAggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’
